LP183524-0
Vilazodone
Active
Description
Vilazodone (United States trade name Viibryd) is a serotonergic antidepressant developed for the treatment of major depressive disorder. In 2009 two phase III clinical trials with positive results were completed. Vilazodone was approved by the FDA for use in the United States to treat major depressive disorder on January 21, 2011. Source: LOINC partner 1
Basic Part Properties
- Part Display Name
- Vilazodone
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2014-03-08
- Construct for LOINC Short Name
- Vilaz
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP183524-0 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP183524-0
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 维拉佐酮 Synonyms: 抗抑郁药; |
| es-ES | Spanish (Spain) | Vilazodona |
| it-IT | Italian (Italy) | Vilazodone |
| tr-TR | Turkish (Turkey) | Vilazodon |
| ru-RU | Russian (Russian Federation) | Вилазодон |
| nl-NL | Dutch (Netherlands) | vilazodon |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright